# Xian Li

> Xian Li is a Series D investor at Kaitai Capital backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Kaitai Capital](https://shizune.co/investors/profile/kaitai-capital)
- Total investments: 1
- Last investment: Oct 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/xian-li-4a5529139

Xian Li is a Series D investor at Kaitai Capital focused on Health Care and Biotechnology. Li Xian is the partner of Kaitai Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Atom Bioscience & Pharmaceutical | Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis. | $82.1M | Series D | Oct 16, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Fortune Capital](https://shizune.co/investors/profile/fortune-capital) — VC Fund, 1 deal together
- [HuaJin Securities](https://shizune.co/investors/profile/huajin-securities) — VC Fund, 1 deal together
- [NNFE Fund Management](https://shizune.co/investors/profile/nnfe-fund-management) — VC Fund, 1 deal together
- [Unifortune](https://shizune.co/investors/profile/unifortune) — VC Fund, 1 deal together

## About Kaitai Capital

VC Fund · Hangzhou, China

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

5 contacts available at Kaitai Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Huang Zehua | Partner | https://shizune.co/investors/profile/huang-zehua |
| Jin Qi | Managing Partner | https://shizune.co/investors/profile/jin-qi-ef05 |
| Li Xianxian | Managing Partner | https://shizune.co/investors/profile/li-xianxian |
| Nannan Chang | Senior Investment Manager | https://shizune.co/investors/profile/nannan-chang |
| Xian Li | Partner | https://shizune.co/investors/profile/xian-li-67ed |

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does Xian Li invest in?

Xian Li invests primarily in Health Care and Biotechnology startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Xian Li last invest?

The most recent investment recorded for Xian Li closed in Oct 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co